The transfection of mesenchymal stem cells (MSCs) using a minicircle expressing the human angiopoietin 1 (ANGPT1) enhanced the MSC therapy by mediating a reduced pulmonary inflammation and lung permeability in lipopolysaccharide-induced acute lung injury (ALI) in mice [52]. This evidence concerns the gene ANGPT1 and acute lung injury.